Last year, the maker of personal care products, branded pharmaceuticals and medical devices completed the integration of Pfizer Consumer Healthcare - a division of the pharma giant that includes Benadryl, Nicorette, Listerine and Sudafed - that it acquired in late 2006 for $16.6 billion. Along with those over-the-counter brands, the company also assumed the rights to Zyrtec, a formerly prescription-only allergy medication that the FDA granted OTC status once the Pfizer patent expired. Armed with a new medicinal treasure chest, revenue grew 14% for the year.
|
Revenues |
61,095.0 |
14.6 |
Profits |
10,576.0 |
-4.3 |
Assets |
80,954.0 |
— |
Stockholders' equity |
43,319.0 |
— |
Market value (3/28/2008) |
181,615.2 |
— |
Revenues |
17.3 |
Assets |
13.1 |
Stockholders' equity |
24.4 |
2007 $ |
3.63 |
% change from 2006 |
-2.7 |
1997-2007 annual growth rate % |
11.7 |
2007 |
3.7 |
1997-2007 annual rate |
9.2 |
4 | Merck | 101 | 24,197.7 | 5 | Wyeth | 113 | 22,399.8 | 6 | Bristol-Myers Squibb | 125 | 19,977.0 | 7 | Eli Lilly | 133 | 18,633.5 | 8 | Amgen | 173 | 14,771.0 | 9 | Schering-Plough | 212 | 12,690.0 | 10 | Gilead Sciences | 536 | 4,230.0 | 11 | Allergan | 554 | 3,958.9 | 12 | Genzyme | 572 | 3,813.5 | 13 | Forest Laboratories | 605 | 3,441.8 | 14 | Hospira | 608 | 3,436.2 | 15 | Biogen Idec | 648 | 3,171.6 | 16 | Mylan | 736 | 2,666.0 | 17 | Barr Pharmaceuticals | 760 | 2,557.6 | 18 | Watson Pharmaceuticals | 775 | 2,496.7 | 19 | King Pharmaceuticals | 857 | 2,136.5 | 20 | NBTY | 894 | 2,014.5 | 21 | Cephalon | 952 | 1,772.6 |
From the May 5, 2008 issue
|
|
See Johnson & Johnson in...
...Featured Companies
(1 of 1)
|